THE PREVALENCE OF SIDE-EFFECTS WITH REGULAR AND SUSTAINED-RELEASE NICOTINIC-ACID

被引:43
|
作者
GIBBONS, LW
GONZALEZ, V
GORDON, N
GRUNDY, S
机构
[1] DALLAS HEART GRP,DALLAS,TX
[2] UNIV TEXAS,SW MED SCH,DALLAS,TX
来源
AMERICAN JOURNAL OF MEDICINE | 1995年 / 99卷 / 04期
关键词
D O I
10.1016/S0002-9343(99)80185-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: TO document the prevalence and nature of the side effects that occur with the use of regular and sustained-release nicotinic acid in everyday clinical practice. PATIENTS AND METHODS: One hundred and ten patients seen in a private medical clinic who were given 133 separate trials of nicotinic acid during a 5-year period. The occurrence of side effects, particularly those severe enough to warrant discontinuing the drug, were carefully monitored. RESULTS: Forty-three percent of individuals given regular nicotinic acid and 42% of those given sustained-release nicotinic acid were forced to discontinue the medication because of side effects; some of these side effects necessitating discontinuing nicotinic acid did not occur until the patient had been taking the drug for 1 or 2 years. CONCLUSION: Nicotinic acid in both regular and sustained-release forms is a powerful drug when used in doses needed to treat lipid disorders and causes disturbing side effects a very high percentage of the time. No one should use nicotinic acid in these doses without continued careful supervision of a physician.
引用
收藏
页码:378 / 385
页数:8
相关论文
共 50 条
  • [31] THE EFFECTS OF NICOTINIC-ACID ON LIPOPROTEINS IN VARIOUS TYPES OF HYPERLIPIDEMIAS
    YOVOS, JG
    FALKO, JM
    PATEL, S
    NEWMAN, HAI
    HILL, D
    CLINICAL RESEARCH, 1981, 29 (02): : A427 - A427
  • [32] EFFECTS OF CLOFIBRATE AND NICOTINIC-ACID ON CHOLESTEROL TURNOVER IN RAT
    PHILLIPS, WA
    RATCHFOR.JM
    ELFRING, GL
    CIRCULATION, 1974, 50 (04) : 269 - 269
  • [33] EFFECTS OF NICOTINIC-ACID ON LIPOPROTEIN METABOLISM AND BILIARY LIPIDS
    ANGELIN, B
    ERICSSON, S
    ERIKSSON, M
    BERGLUND, L
    ATHEROSCLEROSIS VIII, 1989, 817 : 795 - 798
  • [34] EFFECTS OF NICOTINIC-ACID ON HUMAN FIBROBLAST PURINE BIOSYNTHESIS
    BOYLE, JA
    BECKER, MA
    RAIVIO, KO
    SEEGMILLER, JE
    BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 269 (02) : 179 - +
  • [35] INVITRO RELEASE OF NICOTINIC-ACID ALKYL ESTERS FROM POLOXAMER VEHICLES
    WU, HLS
    MILLER, SC
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 66 (1-3) : 213 - 221
  • [36] EFFECT OF SUSTAINED-RELEASE ON THE PHARMACOKINETICS OF VALPROIC ACID IN THE DOG
    BIALER, M
    FRIEDMAN, M
    DUBROVSKY, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 20 (1-2) : 53 - 63
  • [37] PALMITIC ACID AS AN EXCIPIENT IN IMPLANTS FOR SUSTAINED-RELEASE OF INSULIN
    WANG, PY
    BIOMATERIALS, 1991, 12 (01) : 57 - 62
  • [38] REGULAR FORMULATION AND SUSTAINED-RELEASE VERAPAMIL THERAPY IN NORMOTENSION AND IN MILD TO MODERATE HYPERTENSION
    KLEIN, MD
    WEINER, DA
    KELLETT, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (07): : D69 - D73
  • [39] EFFECTS OF FOOD ON THE BIOAVAILABILITY OF SUSTAINED-RELEASE PINACIDIL IN HUMANS
    MCBURNEY, A
    FARROW, PR
    WARD, JW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) : 68 - 69
  • [40] RESPIRATORY AND ANALGESIC EFFECTS OF SUSTAINED-RELEASE ORAL MORPHINE
    MCSHANE, AJ
    BLUNNIE, WP
    IRISH JOURNAL OF MEDICAL SCIENCE, 1985, 154 (08) : 324 - 324